Tanggana, Neneth -.
HRN: 23-34-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2022
CO-AMOXICLAV 625MG (TAB)
12/21/2022
12/28/2022
ORAL
500mg/tab
BID
S/P 3° RMLE With Episiotomy & Episiorrhaphy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes